Dr. Reddy's Laboratories Ltd. · NSE:DRREDDY

Dr. Reddy's Laboratories — Fact Sheet (July 2012)

2 slides from Dr. Reddy's Laboratories's fact sheet, July 2012

  1. Slide 1: Quick Facts FY12

    Quick Facts FY12 Key Company updates: Launched Over-the-Counter fexofenadine HCl tablets Promius™ Pharma & Valeant formed collaboration to market Cloderm® cream in the United States Our identity is a sunny abstract that can be Launched pegfilgrastim in India under the brand name Peg-grafeel ™ interp

  2. Slide 2: Key Highlights FY12

    Key Highlights FY12 Crossed $2 bn in revenues. Fastest in Indian pharma to reach the milestone Approval and launch of fondaparinux Launch of olanzapine 20mg and ziprasidone in the US Commencement of sales at Bristol penicillin facility Limited competition portfolio in US crosses $200 mn OTC portfoli

Dr. Reddy's Laboratories — Fact Sheet (July 2012) on 6ix